unknown1
Selective nano-filtration for precise removal of multivalent ions in pharmaceutical processing. Optimized for high-rejection performance at moderate operating pressures.
Performance Snapshot
Rejection
99.2%
Multivalent ions
Pressure
15 Bar
Rated maximum
Flux Stability
High
Pharma spec
Core Engineering Features
Advanced technological implementations defining the next generation of membrane performance.
Multi-Layer Cross-Linking
Advanced membrane structure offering enhanced resistance to oxidative degradation and extended operational lifespan compared to standard modules.
Optimized Hydrodynamics
Precision spacer design minimizes boundary layer formation and concentration polarization, significantly reducing fouling propensity in demanding feeds.
High-Flux Sustained Output
Engineered to maintain peak permeation rates under variable feed conditions, maximizing plant efficiency and lowering specific energy consumption.
Rigorous ISO Compliance
Manufactured under strict cleanroom conditions meeting ISO 9001:2015 standards, ensuring batch-to-batch consistency and ultimate reliability.
Process Architecture
Pharma-Grade NF Architecture
Cross-sectional view of the Nano-Flow Prime module illustrating sanitary feed geometry, selective rejection layer, and permeate pathways validated for pharmaceutical water systems.
- check_circleSanitary-grade module housing options
- check_circleValidated cleaning and flush protocols
- check_circleLow extractables membrane chemistry
Technical Specifications
Detailed operational parameters for the Nano-Flow Prime module under standard test conditions.
| Parameter | Value |
|---|---|
| MgSO4 Rejection | 99.2% |
| Maximum Pressure | 15 |
| Permeate Flow | 7,500 (28.4) |
| Active Area | 340 (32) |
| Operating pH | 3-10 |
Technical FAQ & Resources
Common engineering inquiries and essential documentation for integration planning.
Yes, it is designed for pharma-grade NF applications including pre-treatment for WFI and purified water systems, with documentation supporting validation workflows.
Typical multivalent ion rejection exceeds 99.2% under standard test conditions, with stable flux over extended production campaigns.
Sanitary tri-clamp and pharma-grade housing configurations are available. Contact our engineering team for integration drawings.